Aethlon Medical (AEMD) News Today $0.78 +0.03 (+3.45%) Closing price 09/18/2025 04:00 PM EasternExtended Trading$0.78 0.00 (-0.26%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEMD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest UpdateSeptember 10, 2025 | americanbankingnews.comAethlon Medical Completes $4.5 Million Public OfferingSeptember 9, 2025 | tipranks.comAethlon Medical announces pricing of $4.5M common stock, warrant offeringSeptember 4, 2025 | msn.comInnovation and IP in Medtech Stocks - How Patents Build LeadersSeptember 4, 2025 | finance.yahoo.comAethlon Medical prices $4.5M public offering with 5-Year warrants; shares down 47%September 4, 2025 | msn.comAethlon Medical Announces Pricing of $4.5 Million Public OfferingSeptember 4, 2025 | prnewswire.comAethlon Medical announces issuance of patents protecting HemopurifierSeptember 3, 2025 | msn.comAethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)September 3, 2025 | finance.yahoo.comAethlon Medical files to sell common stock, warrants, no amount givenAugust 20, 2025 | msn.comAEMD: Cohort 2 Enrollment Open; Initial Cohort 1 Data Analysis Expected Next MonthAugust 19, 2025 | finance.yahoo.comAethlon Medical Reports Q1 2025 Financial ResultsAugust 15, 2025 | msn.comAethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ...August 15, 2025 | finance.yahoo.comAethlon Medical Cuts Loss in Fiscal Q1August 14, 2025 | theglobeandmail.comAethlon Medical signals Australia oncology trial completion by early 2026 while scaling back India plansAugust 14, 2025 | msn.comAethlon Medical, Inc. (NASDAQ:AEMD) Q1 2026 Earnings Call TranscriptAugust 14, 2025 | msn.comAethlon Medical, Inc. (AEMD) Q1 2026 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comAethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate UpdateAugust 13, 2025 | prnewswire.comAethlon Medical Q1 2026 Earnings PreviewAugust 12, 2025 | msn.comAethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025August 5, 2025 | prnewswire.comAEMD: No SAEs in Cohort 1 Post-Hemopurifier Treatment; Progressing Trial to Cohort 2July 17, 2025 | finance.yahoo.comAethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial CohortJuly 15, 2025 | prnewswire.comAEMD - Aethlon Medical Inc Ownership - MorningstarJuly 5, 2025 | morningstar.comMAethlon’s Earnings Call: Clinical Progress Amid Financial HurdlesJuly 4, 2025 | theglobeandmail.comAEMD: Progressing & Expanding Clinical & Pre-Clinical Activities in Cost Efficient MannerJuly 2, 2025 | finance.yahoo.comAethlon Medical Inc (AEMD) Share Chat - Investing.com UKJune 29, 2025 | uk.investing.comAethlon Medical Reports Progress in Cancer TrialsJune 26, 2025 | tipranks.comAethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call TranscriptJune 26, 2025 | seekingalpha.comEarnings Scheduled For June 26, 2025June 26, 2025 | benzinga.comAethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate UpdateJune 26, 2025 | prnewswire.comAethlon Medical, Inc. (AEMD) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comAEMD Aethlon Medical, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comAethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025June 20, 2025 | prnewswire.comAethlon Medical at Emerging Growth Conference 83: Strategic Updates on HemopurifierJune 19, 2025 | investing.comAethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer TrialJune 18, 2025 | prnewswire.comAEMD: Virtual Meeting With Management, Upcoming Presentation of Data in Long CovidJune 12, 2025 | finance.yahoo.comAethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection SyndromesJune 9, 2025 | prnewswire.comAethlon Medical Approves Reverse Stock Split PlanJune 5, 2025 | tipranks.comAethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from PlasmaMay 14, 2025 | prnewswire.comAethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology JournalMarch 10, 2025 | prnewswire.comAethlon Medical (AEMD) Receives a Hold from Maxim GroupFebruary 14, 2025 | markets.businessinsider.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 13, 2025 | finance.yahoo.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 13, 2025 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call TranscriptFebruary 13, 2025 | msn.comAethlon Medical to Present at the Emerging Growth Conference on February 19, 2025February 13, 2025 | prnewswire.comAethlon Medical strengthens oncology trial with protocol updates and cost reductionsFebruary 12, 2025 | msn.comAethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call TranscriptFebruary 12, 2025 | seekingalpha.comAethlon Medical reports Q3 EPS (13c), consensus (20c)February 12, 2025 | markets.businessinsider.comAethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate UpdateFebruary 12, 2025 | prnewswire.comAethlon Medical Q3 2025 Earnings PreviewFebruary 12, 2025 | msn.comAethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025February 5, 2025 | prnewswire.com Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AEMD Media Mentions By Week AEMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEMD News Sentiment▼0.000.63▲Average Medical News Sentiment AEMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEMD Articles This Week▼01▲AEMD Articles Average Week Get the Latest News and Ratings for AEMD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aethlon Medical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HSCS News AMIX News SSKN News LUCY News PTHL News NAOV News IVF News QNRX News CHEK News BBLG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEMD) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.